Regenerative Medicine Market Key Growth Drivers and Leading Players

FAQ's

Answer : According to Precedence Research, the global precision medicine market size was valued at USD 66.1 billion in 2021 and is expected to reach USD 175.64 billion by 2030.

Answer : The global precision medicine market is poised to grow at a compound annual growth rate (CAGR) of 11.5% during the forecast period 2022 to 2030.

Answer : The advent of precision medicine has significantly brought a paradigm shift in the drug delivery and diagnosis of the disease. The proliferation of sequencing methodologies, particularly Next Generation Sequencing (NGS), due to the increasing cost of sequencing and development of the Human Genome Project in the field of genomics is predicted to drive the market.

Answer : North America dominated the global precision medicine market with revenue share of nearly 40% in 2019 and expected to grow at an escalating pace during the forecast period.

Answer : Some of the key players operating in the market are Biocrates Life Sciences, TepnelPharma Services, Novartis, Qiagen, Quest Diagnostics, Menarini Silicon Biosystems, NanoString Technologies, Eagle Genomics, Pfizer, Intomics, Roche, and Teva Pharmaceutical among others.

Answer : The Asia Pacific seeks lucrative growth over the forecast period due to low cost clinical trials of newly developed diagnostic products and precision medicine. Furthermore, rising disposable income and rising economy in the developing nations such as India expected to boost the demand of precision medicines in the region.

Answer : By technology, drug discovery registered considerable growth in the recent past and expect to lead the overall market revenue in 2019.

Answer : Oncology application led the global precision medicine market with significant revenue share in 2019 and analyzed to grow at a prominent rate during the forecast period.